Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis

Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis

US Patent 11179440 · Granted Nov 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Semiconductor device and method for fabricating the same2025
Semiconductor device and method for fabricating the same2025
Sensor applicator assembly for continuous glucose monitoring system2025
Body attachable unit for continuous blood glucose measurement2025
Two-chamber type combined container-syringe2025
Method for manufacturing insertion guide needle for continuous blood glucose mon2025
Semiconductor device and method for fabricating the same2025
Salt of an aminopyridine derivative compound, a crystalline form thereof, and a 2025
Salt of an aminopyridine derivative compound, a crystalline form thereof, and a 2025
Continuous blood glucose measurement sensor2025
Robot and method for generating map thereby2025
Auxiliary adhesive patch of body attachable unit for continuous blood glucose mo2025